PINK
CNNA

Cann American Corp

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Cann American Corp Stock Price

Vitals

Today's Low:
$0.0009
Today's High:
$0.0009
Open Price:
$0.0009
52W Low:
$0.001
52W High:
$0.0178
Prev. Close:
$0.0009
Volume:
0

Company Statistics

Market Cap.:
$421
Book Value:
0.001
Revenue TTM:
$13230
Operating Margin TTM:
-2126.42%
Gross Profit TTM:
$16710
Profit Margin:
0%
Return on Assets TTM:
-84.62%
Return on Equity TTM:
-259.65%

Company Profile

Cann American Corp had its IPO on under the ticker symbol CNNA.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Cann American Corp has a staff strength of 1 employees.

Stock update

Shares of Cann American Corp opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Cann American Corp have slipped by -18.18%.

Cann American Corp's Key Ratios

Cann American Corp has a market cap of $421, indicating a price to book ratio of 0.0007 and a price to sales ratio of 0.0306.

In the last 12-months Cann American Corp’s revenue was $13230 with a gross profit of $16710 and an EBITDA of $-275984. The EBITDA ratio measures Cann American Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cann American Corp’s operating margin was -2126.42% while its return on assets stood at -84.62% with a return of equity of -259.65%.

In Q2.6666666666667, Cann American Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 50.7%.

Cann American Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-41.29 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cann American Corp’s profitability.

Cann American Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.0002. Its price to sales ratio in the trailing 12-months stood at 0.0306.

Cann American Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0
Total Liabilities
$8655.00
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Cann American Corp ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.

Cann American Corp ended 2024 with $0 in deferred long-term liabilities, $8655.00 in other current liabilities, 927419.00 in common stock, $-5387366.00 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Cann American Corp’s total current assets stands at $174497.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $8655.00 and inventory worth $0.

In 2024, Cann American Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Cann American Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0
52-Week High
$0.0178
52-Week Low
$0.001
Analyst Target Price
$

Cann American Corp stock is currently trading at $0 per share. It touched a 52-week high of $0.0178 and a 52-week low of $0.0178. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 953% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Cann American Corp

The stock symbol (also called stock or share ticker) of Cann American Corp is CNNA

The IPO of Cann American Corp took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$33.4
-1.24
-3.58%
$9.27
-0.05
-0.54%
$8.39
0
0%
$0.24
-0
-0.99%
$1795.65
-159.55
-8.16%
$3.04
-0.34
-10.06%
$3.14
-0.16
-4.85%
$12.1
0.9
+8.04%
Tilray Inc (TLRY)
$2.91
-0.4
-12.08%
$23.3
-0.51
-2.13%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was founded in 2004 and is based in Cloverdale, California.

Address

320 Santana Drive, Cloverdale, CA, United States, 95425